Target intelligence / Profile preview

C-C motif chemokine 1 (CCL1)

Target
CCL1
Molecular classification
Other, Chemokine, Cytokine
01

Overview

C-C motif chemokine 1 (CCL1), also known as I-309, is a small glycoprotein belonging to the CC chemokine family that is secreted by activated T cells, monocytes, macrophages, and endothelial cells. It acts as a potent chemoattractant primarily for monocytes and T lymphocytes, particularly Th2-differentiated T cells and regulatory T cells (Tregs), by binding to its primary receptor, C-C chemokine receptor type 8 (CCR8). In the tumor microenvironment, the CCL1-CCR8 axis plays a critical role in tumor immune evasion by recruiting immunosuppressive Tregs, which shield tumor cells from cytotoxic T cell attacks. Consequently, targeting CCL1 or its receptor CCR8 has emerged as a highly promising strategy in cancer immunotherapy to deplete tumor-infiltrating Tregs and restore anti-tumor immunity. Beyond oncology, CCL1 is implicated in chronic inflammatory and autoimmune diseases, such as atopic dermatitis, asthma, and rheumatoid arthritis, as well as in pulmonary and hepatic fibrosis through its interaction with CCR8 and the novel receptor autocrine motility factor receptor (AMFR). Therapeutic approaches targeting CCL1 include neutralizing monoclonal antibodies, antisense oligonucleotides, and small-molecule inhibitors designed to disrupt its signaling pathways and restore immune balance.

Other names
C-C motif chemokine ligand 1Chemokine (C-C motif) ligand 1Small-inducible cytokine A1T lymphocyte-secreted protein I-309I-309TCA3SCYA1
02

Mechanism of action

Neutralization of the chemokine ligand to prevent receptor binding, antisense knockdown of chemokine mRNA to inhibit protein expression, or small-molecule antagonism of its receptor CCR8 to block downstream signaling pathways.

03

Biological functions

Immune responseSignal transductionCell migrationChemotaxisOther
04

Disease associations

CancerInflammationOther
05

Safety considerations

Disruption of systemic immune homeostasisImpaired immune tolerance leading to autoimmunityIncreased susceptibility to opportunistic infectionsImpaired tissue repair and wound healing
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

CCL1 serum levelsCCL1 bronchoalveolar lavage fluid levelsCCR8 expression on regulatory T cells

Beyond the preview

Go deeper on C-C motif chemokine 1 (CCL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-C motif chemokine 1 (CCL1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call